Lupin appoints Theresa Stevens as Chief Corporate Development Officer
Has over 27 years of experience in the Pharmaceutical and Biotech sector Pharma major Lupin announced the appointment of Theresa…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
IDMA to organise seminar on “FDCs: The Way Forward” in Mumbai
Will enlighten on the relevance of FDCs vis-à-vis the global practices The Indian Drug Manufacturers’ Association (IDMA) in…
Glatt India inaugurates its second office in Delhi
Signs a contract worth 3 million euros with a client from Saudi Arabia
GAVI Alliance to present plans to expand impact of vaccines by 2020
Drive to secure a healthy future for children in developing countries
Cole-Parmer launches new Digi-Sense line of precision measurement instruments
Cole-Parmer has introduced a comprehensive new line of test and measurement products to fill the technician’s toolbelt. The…
OMRON opens its first ATC in Mumbai
A state-of-the-art facility for the customers to help them make the best of their investment in industrial automation
Dr Rao VSV Vadlamudi elected President of IPA
SD Joag has been appointed as Secretary General of IPA
DRL launches Fenofibrate capsules, USP 43 mg and 130 mg
Dr Reddy’s Laboratories (DRL) has launched Fenofibrate capsules, USP 43 mg and 130 mg a therapeutic equivalent generic version of…
Lupin inks joint venture agreement with Yoshindo
New entity YL Biologics to focus on clinical development and commercialisation of biosimilars for Japan
Patent protection losses will hinder HIV treatment market growth within seven years: GBI Research
The first-line antiretroviral therapies Atripla and Truvada will lose patent protection during the forecast period, which will…
US FDA approves Cyramza for stomach cancer
Cyramza is an angiogenesis inhibitor that blocks the blood supply to tumours
UBM India to organise 3rd Annual Global Pharma Regulatory Summit 2014
Event to be held in Mumbai from April 23 to 25, 2014
Eppendorf launches electronic microinjectors, FemtoJet 4i and FemtoJet 4x
These electronic micro-injectors claim to deliver high levels of reproducibility and precision
IDMA to organise conference on ‘Current Challenges & Opportunities in Pharma…
The theme of the conference is 'Indian Pharmaceuticals for Global Health.'
US FDA approves ofatumumab
Ofatumumab in combination with chlorambucil is effective for the treatment of previously untreated patients with chronic…
Quintiles recognised as industry leader in phase II/III research
Preferred provider among small, mid-size and large biopharmaceutical customers
SCHOTT India acquitted of anti-competitive conduct
Competition Appellate Tribunal rules in favour of SCHOTT India against the Competition Commission of India and Kapoor Glass
Thomson Reuters names 2014 leading drugs to watch
Analysis points to three potential blockbusters: Sovaldi, Anoro Ellipta and Idelalisib entering market this year
Piramal to acquire 20 per cent equity stake in Shriram Capital
Piramal had invested Rs 1,636 crore in May last year to acquire ~9.9 per cent equity in Shriram Transport Finance Company